WGU D398 Pharmacology OA Exam Prep | 2026/2027
WGU D398 PHARMACOLOGY OA EXAM |
2026/2027 Edition | 60 Verified Questions
WGU D398 INTRODUCTION TO PHARMACOLOGY OBJECTIVE ASSESSMENT (OA)
ACTUAL EXAM 2026 /2027
100% Verified Solutions | Updated Per Latest WGU & Pharmacology Guidelines |
Graded A+
This comprehensive exam is designed for nursing students preparing for the WGU D398
Introduction to Pharmacology Objective Assessment. It covers essential pharmacological
concepts including pharmacokinetics, pharmacodynamics, drug classifications, mechanisms of
action, therapeutic uses, adverse effects, and nursing considerations. Each question has been
carefully constructed to align with the 2026/2027 WGU curriculum and current FDA guidelines,
ensuring thorough preparation for the Objective Assessment.
Key Features
✓ Pharmacokinetics and pharmacodynamics principles
✓ Autonomic and cardiovascular drug classifications
✓ Antimicrobial and antineoplastic agents
✓ CNS and pain management pharmacology
✓ Nursing considerations and patient education
Updates for 2026
1. Updated FDA black box warnings for novel anticoagulants (DOACs) including revised
bleeding risk protocols and specific reversal agent availability
2. Revised antimicrobial stewardship and resistance protocols reflecting the 2026 CDC
guidelines on multidrug-resistant organisms and appropriate antibiotic selection
3. New clinical guidelines for GLP-1 receptor agonists and opioid stewardship, including
updated dosing recommendations and expanded indications for semaglutide
Abstract
This document provides a structured review of foundational pharmacology aligned with the
WGU D398 Introduction to Pharmacology Objective Assessment competencies. It encompasses the
core principles of pharmacokinetics, including absorption, distribution, metabolism, and excretion,
as well as pharmacodynamics concepts such as receptor theory, agonist-antagonist relationships,
and dose-response curves. The content addresses major drug classifications across autonomic,
cardiovascular, antimicrobial, central nervous system, endocrine, and respiratory pharmacology.
Emphasis is placed on drug mechanisms of action, safe medication administration protocols,
adverse effect monitoring, critical nursing interventions, and evidence-based patient education
strategies. Each question integrates clinical reasoning with current FDA guidelines and evidence-
based pharmacological principles to prepare students for the Objective Assessment.
Keywords
WGU D398, Introduction to Pharmacology, Pharmacokinetics, Pharmacodynamics, Nursing
Pharmacology, Medication Administration, Drug Classifications, Objective Assessment
Answer Format
Correct answers are displayed in bold. Each question includes a detailed rationale in italicized
explaining the correct answer, followed by a "Why Wrong" section analyzing each distractor, and a
specific reference to the 2026 WGU D398 course module, pharmacology textbook, or FDA guideline.
Questions and choices are rendered in Black (#000000) for maximum readability.
1
, WGU D398 Pharmacology OA Exam Prep | 2026/2027
Content Area Overview
Content Area Questions Key Topics Weight
Pharmacokinetics & 1–12 ADME, half-life, TI, CYP enzymes, 20%
Pharmacodynamics receptor theory
Autonomic & Cardiovascular 13–24 Alpha/beta blockers, ACE inhibitors, 20%
Drugs anticoagulants, statins
Antimicrobials & Immune 25–36 Antibiotics, antifungals, antivirals, 20%
Drugs immunosuppressants
CNS & Pain Management 37–48 Antiepileptics, antidepressants, opioids, 20%
anxiolytics
Endocrine & Respiratory 49–60 Insulin, corticosteroids, thyroid drugs, 20%
Pharmacology bronchodilators
Examination Questions
Domain: Pharmacokinetics & Pharmacodynamics
1. A patient receives a drug intravenously. Which pharmacokinetic phase is
bypassed?
A. Distribution
B. Absorption
C. Metabolism
D. Excretion
Correct Answer: B
Rationale: Intravenous administration delivers the drug directly into the bloodstream,
completely bypassing the absorption phase that is required for oral, intramuscular, or
subcutaneous routes. This results in 100% bioavailability and an immediate onset of action.
Why Wrong: A: Distribution still occurs as the drug moves from blood to tissues. C: Metabolism
still occurs in the liver or other organs. D: Excretion still occurs via kidneys or other routes.
Reference: Lehne's Pharmacology for Nursing Care, 12th Ed., Chapter 3
2. A drug with a high first-pass effect is prescribed. Which route minimizes this
effect?
A. Oral
B. Rectal
C. Sublingual
D. Enteral
Correct Answer: C
Rationale: Sublingual administration allows the drug to be absorbed through the oral mucosa
directly into the systemic circulation, bypassing the portal circulation and the liver's first-pass
metabolism. This significantly increases bioavailability compared to oral or rectal routes.
Why Wrong: A: Oral route subjects the drug to the greatest first-pass effect. B: Rectal route
partially avoids first-pass but not as effectively as sublingual. D: Enteral routes include oral and
rectal, both subject to first-pass effects.
Reference: Rosenthal & Burchum, Lehne's Pharmacology, Chapter 4
3. Which statement best describes the therapeutic index (TI)?
A. The ratio of the toxic dose to the therapeutic dose
B. The ratio of the therapeutic dose to the toxic dose
C. The time required for half the drug to be eliminated
D. The volume of distribution divided by clearance
Correct Answer: A
2
, WGU D398 Pharmacology OA Exam Prep | 2026/2027
Rationale: The therapeutic index is defined as the ratio of the toxic dose (TD50) to the effective
dose (ED50). A high TI indicates a wide margin of safety, meaning the drug is relatively safe,
whereas a low TI indicates a narrow margin requiring careful monitoring.
Why Wrong: B: This is the inverse and is not the standard definition. C: This describes the half-
life, not the therapeutic index. D: This is a fabricated formula with no pharmacological meaning.
Reference: WGU D398 Course Module 1: Pharmacokinetics
4. A patient has a creatinine clearance of 25 mL/min. What pharmacokinetic
parameter is most affected?
A. Absorption
B. Distribution
C. Metabolism
D. Excretion
Correct Answer: D
Rationale: Creatinine clearance is a measure of renal function. A value of 25 mL/min indicates
severe renal impairment, which directly affects the excretion of drugs eliminated by the kidneys.
Drug clearance is reduced, leading to drug accumulation and potential toxicity if dosing is not
adjusted.
Why Wrong: A: Absorption is primarily affected by GI function, not renal function. B:
Distribution may be slightly affected by fluid changes, but excretion is the primary concern. C:
Metabolism occurs primarily in the liver and is not directly affected by renal clearance.
Reference: Lehne's Pharmacology for Nursing Care, Chapter 5
5. A drug that binds to a receptor and produces a maximal response is classified as a:
A. Partial agonist
B. Full agonist
C. Competitive antagonist
D. Inverse agonist
Correct Answer: B
Rationale: A full agonist binds to a receptor and activates it, producing the maximal biological
response possible. This is in contrast to a partial agonist, which produces a submaximal response
even at full receptor occupancy.
Why Wrong: A: A partial agonist produces a submaximal response. C: A competitive antagonist
blocks the receptor without activating it. D: An inverse agonist reduces constitutive receptor
activity below baseline.
Reference: WGU D398 Course Module 2: Pharmacodynamics
6. Which Cytochrome P450 enzyme is responsible for metabolizing the largest
percentage of drugs?
A. CYP2D6
B. CYP2C9
C. CYP3A4
D. CYP1A2
Correct Answer: C
Rationale: CYP3A4 is the most abundant CYP enzyme in the liver and intestines and is
responsible for metabolizing approximately 50% of all clinically used drugs. It plays a critical
role in drug-drug interactions and first-pass metabolism.
Why Wrong: A: CYP2D6 metabolizes about 25% of drugs but is less abundant than CYP3A4. B:
CYP2C9 metabolizes about 10% of drugs. D: CYP1A2 metabolizes a smaller percentage of drugs
compared to CYP3A4.
Reference: Rosenthal & Burchum, Lehne's Pharmacology, Chapter 6
7. What is the primary mechanism by which grapefruit juice increases drug levels of
certain medications?
A. Inhibition of intestinal CYP3A4
B. Induction of hepatic CYP2D6
C. Increased P-glycoprotein efflux
D. Enhanced gastric absorption
Correct Answer: A
3
WGU D398 PHARMACOLOGY OA EXAM |
2026/2027 Edition | 60 Verified Questions
WGU D398 INTRODUCTION TO PHARMACOLOGY OBJECTIVE ASSESSMENT (OA)
ACTUAL EXAM 2026 /2027
100% Verified Solutions | Updated Per Latest WGU & Pharmacology Guidelines |
Graded A+
This comprehensive exam is designed for nursing students preparing for the WGU D398
Introduction to Pharmacology Objective Assessment. It covers essential pharmacological
concepts including pharmacokinetics, pharmacodynamics, drug classifications, mechanisms of
action, therapeutic uses, adverse effects, and nursing considerations. Each question has been
carefully constructed to align with the 2026/2027 WGU curriculum and current FDA guidelines,
ensuring thorough preparation for the Objective Assessment.
Key Features
✓ Pharmacokinetics and pharmacodynamics principles
✓ Autonomic and cardiovascular drug classifications
✓ Antimicrobial and antineoplastic agents
✓ CNS and pain management pharmacology
✓ Nursing considerations and patient education
Updates for 2026
1. Updated FDA black box warnings for novel anticoagulants (DOACs) including revised
bleeding risk protocols and specific reversal agent availability
2. Revised antimicrobial stewardship and resistance protocols reflecting the 2026 CDC
guidelines on multidrug-resistant organisms and appropriate antibiotic selection
3. New clinical guidelines for GLP-1 receptor agonists and opioid stewardship, including
updated dosing recommendations and expanded indications for semaglutide
Abstract
This document provides a structured review of foundational pharmacology aligned with the
WGU D398 Introduction to Pharmacology Objective Assessment competencies. It encompasses the
core principles of pharmacokinetics, including absorption, distribution, metabolism, and excretion,
as well as pharmacodynamics concepts such as receptor theory, agonist-antagonist relationships,
and dose-response curves. The content addresses major drug classifications across autonomic,
cardiovascular, antimicrobial, central nervous system, endocrine, and respiratory pharmacology.
Emphasis is placed on drug mechanisms of action, safe medication administration protocols,
adverse effect monitoring, critical nursing interventions, and evidence-based patient education
strategies. Each question integrates clinical reasoning with current FDA guidelines and evidence-
based pharmacological principles to prepare students for the Objective Assessment.
Keywords
WGU D398, Introduction to Pharmacology, Pharmacokinetics, Pharmacodynamics, Nursing
Pharmacology, Medication Administration, Drug Classifications, Objective Assessment
Answer Format
Correct answers are displayed in bold. Each question includes a detailed rationale in italicized
explaining the correct answer, followed by a "Why Wrong" section analyzing each distractor, and a
specific reference to the 2026 WGU D398 course module, pharmacology textbook, or FDA guideline.
Questions and choices are rendered in Black (#000000) for maximum readability.
1
, WGU D398 Pharmacology OA Exam Prep | 2026/2027
Content Area Overview
Content Area Questions Key Topics Weight
Pharmacokinetics & 1–12 ADME, half-life, TI, CYP enzymes, 20%
Pharmacodynamics receptor theory
Autonomic & Cardiovascular 13–24 Alpha/beta blockers, ACE inhibitors, 20%
Drugs anticoagulants, statins
Antimicrobials & Immune 25–36 Antibiotics, antifungals, antivirals, 20%
Drugs immunosuppressants
CNS & Pain Management 37–48 Antiepileptics, antidepressants, opioids, 20%
anxiolytics
Endocrine & Respiratory 49–60 Insulin, corticosteroids, thyroid drugs, 20%
Pharmacology bronchodilators
Examination Questions
Domain: Pharmacokinetics & Pharmacodynamics
1. A patient receives a drug intravenously. Which pharmacokinetic phase is
bypassed?
A. Distribution
B. Absorption
C. Metabolism
D. Excretion
Correct Answer: B
Rationale: Intravenous administration delivers the drug directly into the bloodstream,
completely bypassing the absorption phase that is required for oral, intramuscular, or
subcutaneous routes. This results in 100% bioavailability and an immediate onset of action.
Why Wrong: A: Distribution still occurs as the drug moves from blood to tissues. C: Metabolism
still occurs in the liver or other organs. D: Excretion still occurs via kidneys or other routes.
Reference: Lehne's Pharmacology for Nursing Care, 12th Ed., Chapter 3
2. A drug with a high first-pass effect is prescribed. Which route minimizes this
effect?
A. Oral
B. Rectal
C. Sublingual
D. Enteral
Correct Answer: C
Rationale: Sublingual administration allows the drug to be absorbed through the oral mucosa
directly into the systemic circulation, bypassing the portal circulation and the liver's first-pass
metabolism. This significantly increases bioavailability compared to oral or rectal routes.
Why Wrong: A: Oral route subjects the drug to the greatest first-pass effect. B: Rectal route
partially avoids first-pass but not as effectively as sublingual. D: Enteral routes include oral and
rectal, both subject to first-pass effects.
Reference: Rosenthal & Burchum, Lehne's Pharmacology, Chapter 4
3. Which statement best describes the therapeutic index (TI)?
A. The ratio of the toxic dose to the therapeutic dose
B. The ratio of the therapeutic dose to the toxic dose
C. The time required for half the drug to be eliminated
D. The volume of distribution divided by clearance
Correct Answer: A
2
, WGU D398 Pharmacology OA Exam Prep | 2026/2027
Rationale: The therapeutic index is defined as the ratio of the toxic dose (TD50) to the effective
dose (ED50). A high TI indicates a wide margin of safety, meaning the drug is relatively safe,
whereas a low TI indicates a narrow margin requiring careful monitoring.
Why Wrong: B: This is the inverse and is not the standard definition. C: This describes the half-
life, not the therapeutic index. D: This is a fabricated formula with no pharmacological meaning.
Reference: WGU D398 Course Module 1: Pharmacokinetics
4. A patient has a creatinine clearance of 25 mL/min. What pharmacokinetic
parameter is most affected?
A. Absorption
B. Distribution
C. Metabolism
D. Excretion
Correct Answer: D
Rationale: Creatinine clearance is a measure of renal function. A value of 25 mL/min indicates
severe renal impairment, which directly affects the excretion of drugs eliminated by the kidneys.
Drug clearance is reduced, leading to drug accumulation and potential toxicity if dosing is not
adjusted.
Why Wrong: A: Absorption is primarily affected by GI function, not renal function. B:
Distribution may be slightly affected by fluid changes, but excretion is the primary concern. C:
Metabolism occurs primarily in the liver and is not directly affected by renal clearance.
Reference: Lehne's Pharmacology for Nursing Care, Chapter 5
5. A drug that binds to a receptor and produces a maximal response is classified as a:
A. Partial agonist
B. Full agonist
C. Competitive antagonist
D. Inverse agonist
Correct Answer: B
Rationale: A full agonist binds to a receptor and activates it, producing the maximal biological
response possible. This is in contrast to a partial agonist, which produces a submaximal response
even at full receptor occupancy.
Why Wrong: A: A partial agonist produces a submaximal response. C: A competitive antagonist
blocks the receptor without activating it. D: An inverse agonist reduces constitutive receptor
activity below baseline.
Reference: WGU D398 Course Module 2: Pharmacodynamics
6. Which Cytochrome P450 enzyme is responsible for metabolizing the largest
percentage of drugs?
A. CYP2D6
B. CYP2C9
C. CYP3A4
D. CYP1A2
Correct Answer: C
Rationale: CYP3A4 is the most abundant CYP enzyme in the liver and intestines and is
responsible for metabolizing approximately 50% of all clinically used drugs. It plays a critical
role in drug-drug interactions and first-pass metabolism.
Why Wrong: A: CYP2D6 metabolizes about 25% of drugs but is less abundant than CYP3A4. B:
CYP2C9 metabolizes about 10% of drugs. D: CYP1A2 metabolizes a smaller percentage of drugs
compared to CYP3A4.
Reference: Rosenthal & Burchum, Lehne's Pharmacology, Chapter 6
7. What is the primary mechanism by which grapefruit juice increases drug levels of
certain medications?
A. Inhibition of intestinal CYP3A4
B. Induction of hepatic CYP2D6
C. Increased P-glycoprotein efflux
D. Enhanced gastric absorption
Correct Answer: A
3
